EGFR-T790M specific small molecule reversible inhibitors (Chung-Ang University)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameEGFR-T790M specific small molecule reversible inhibitors (Chung-Ang University)
Drug Alias NameMK-1079MK-1320MK-1068MK-1279MK-1328 +[7] 
ClassificationSmall molecules
Mechanisms of ActionAnticancer protein kinase inhibitorsEpidermal growth factor receptor erbB1 antagonists
TargetsEpidermal growth factor receptor erbB1
Therapy Area/IndicationsCarcinoma, Non-Small-Cell Lung
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesChung-Ang University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesChung-Ang University
Active IndicationsN/A
Inactive IndicationsCarcinoma, Non-Small-Cell Lung

Other Information

ATC CodeN/A
Related LinksN/A